Carbohydrate counting implementation on pediatric type 1 diabetes mellitus: systematic review and meta-analysis

Lowilius Wiyono1, Nida Ghitha1, Dina Clarisa1

  • 1Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.

Insights

Carbohydrate counting effectively reduces hemoglobin A1c (HbA1c) in children with type 1 diabetes mellitus. This management strategy improves glycemic control, offering a valuable approach for pediatric diabetes care.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Evidence-Based Medicine

Background:

  • Type 1 diabetes mellitus (T1DM) is the most prevalent form of diabetes in children.
  • Effective management of T1DM is crucial for preventing long-term complications and maintaining quality of life.
  • Carbohydrate counting is a key dietary management strategy for T1DM.

Purpose of the Study:

  • To systematically review and meta-analyze the efficacy of carbohydrate counting in reducing HbA1c levels in pediatric T1DM patients.
  • To evaluate the impact of carbohydrate counting on glycemic control in children with T1DM.

Main Methods:

  • A systematic review and meta-analysis of nine relevant studies.
  • Searched electronic databases including ProQuest, PubMed, Scopus, and ScienceDirect.
  • Assessed study quality using risk of bias and JBI Critical Appraisal tools.
  • Performed quantitative analysis and forest plot extrapolation.

Main Results:

  • Meta-analysis of nine studies involving pediatric T1DM patients demonstrated a significant reduction in HbA1c.
  • Carbohydrate counting intervention resulted in a mean HbA1c difference of -0.55 (95% CI, -0.81 to -0.28; P<0.001) compared to control groups.
  • High heterogeneity (I2=88%) was noted across the included studies, indicating variability in results.

Conclusions:

  • The meta-analysis provides evidence supporting the use of carbohydrate counting in managing T1DM in children.
  • Carbohydrate counting is an effective intervention for improving glycemic control in pediatric patients with type 1 diabetes mellitus.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.2K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.1K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
189
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
292
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K